Medicare Enrolled
Dr. David Kim, M.D.
Gastroenterology · Arlington Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. David Kim is a gastroenterology specialist in Arlington Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 9,009 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kim received a total of $122,861 from 46 pharmaceutical and/or device companies across 595 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in IL
$122,861 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,009
Medicare services
Top 2% in IL for gastroenterology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
6,600 | $17 | $50 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,290 | $26 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
247 | $98 | $212 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
186 | $65 | $200 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
126 | $104 | $1,245 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
94 | $225 | $1,425 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
84 | $79 | $924 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
84 | $8 | $140 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $106 | $328 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $109 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $52 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $128 | $300 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
27 | $66 | $250 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
23 | $86 | $900 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
22 | $53 | $146 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
19 | $109 | $390 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
19 | $23 | $250 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
19 | $191 | $1,399 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
14 | $155 | $1,190 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
11 | $170 | $1,256 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
88.0% high complexity
3.3% medium
8.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$122,861
Total received (2018-2024)
Avg $17,552/year across 7 years
Top 5% in IL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
595
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,596
2023
$2,113
2022
$8,411
2021
$18,981
2020
$14,801
2019
$38,835
2018
$33,123
Payments by company (2024)
Madrigal Pharmaceuticals
$3,906
Janssen Biotech, Inc.
$640
ABBVIE INC.
$497
Takeda Pharmaceuticals U.S.A., Inc.
$400
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$218
Ipsen Biopharmaceuticals, Inc
$203
Intercept Pharmaceuticals, Inc.
$134
Regeneron Healthcare Solutions, Inc.
$106
PFIZER INC.
$94
QOL Medical, LLC
$91
Lilly USA, LLC
$72
Phathom Pharmaceuticals, Inc.
$58
IRONWOOD PHARMACEUTICALS, INC
$53
Celltrion USA Inc.
$34
Ardelyx, Inc.
$23
Merck Sharp & Dohme LLC
$18
Mirum Pharmaceuticals, Inc.
$17
Exact Sciences Corporation
$17
Celgene Corporation
$14
Top 3 companies account for 76.4% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$74,080
AbbVie, Inc.
$35,921
Madrigal Pharmaceuticals
$3,906
Janssen Biotech, Inc.
$1,274
INTERCEPT PHARMACEUTICALS, INC.
$1,238
Intercept Pharmaceuticals, Inc.
$1,204
ABBVIE INC.
$1,045
Takeda Pharmaceuticals U.S.A., Inc.
$977
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$778
AbbVie Inc.
$359
Ipsen Biopharmaceuticals, Inc
$203
PFIZER INC.
$179
Celgene Corporation
$155
Echosens North America, Inc.
$140
QOL Medical, LLC
$126
Regeneron Healthcare Solutions, Inc.
$106
Lilly USA, LLC
$72
UCB, Inc.
$70
VIVUS LLC
$69
GENZYME CORPORATION
$60
Phathom Pharmaceuticals, Inc.
$58
Braintree Laboratories, Inc.
$58
Ardelyx, Inc.
$55
Amgen Inc.
$54
IRONWOOD PHARMACEUTICALS, INC
$53
Ironwood Pharmaceuticals, Inc
$51
Exact Sciences Corporation
$50
Shire North American Group Inc
$48
Merck Sharp & Dohme Corporation
$42
Merck Sharp & Dohme LLC
$39
W. L. Gore & Associates, Inc.
$39
Nestle HealthCare Nutrition Inc.
$37
Medtronic USA, Inc.
$35
Celltrion USA Inc.
$34
Alexion Pharmaceuticals, Inc.
$31
Evoke Pharma, Inc.
$29
Daiichi Sankyo Inc.
$25
Sandoz Inc.
$24
Romark Laboratories, LC
$23
Organon LLC
$22
Ferring Pharmaceuticals Inc.
$19
Mirum Pharmaceuticals, Inc.
$17
Allergan Inc.
$16
Dova Pharmaceuticals
$14
Concordia Pharmaceuticals Inc.
$13
Napo Pharmaceuticals Inc
$13
Top 3 companies account for 92.7% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRISO · AVSOLA · Amitiza · CREON · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Donnatal · Doptelet · ENTYVIO · EOHILIA · Entyvio · Epclusa · FibroScan · GATTEX · GIMOTI · GORE CARDIOFORM Septal Occluder · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · INTELLIS · IQIRVO · Kanuma · LINZESS · Linzess · Livmarli · MAVYRET · Mavyret · Mytesi · OCALIVA · OMVOH · QSYMIA · Qsymia · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · STRENSIQ · SUCRAID · SUTAB · Sucraid · TREMFYA · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · Vemlidy · Viread · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
410
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a mixed practice specialist, with above-average Medicare volume (top 2% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Kim performed 6,600 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $122,861 from 46 companies across 595 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other gastroenterologists in Arlington Heights?
Dr. Kim's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Arlington Heights
Browse gastroenterologists in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in IL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in IL
Which IL gastroenterologists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Madrigal Pharmaceuticals Payments to Doctors
See all physicians who received payments from Madrigal Pharmaceuticals.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology